Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (3)

2024

  1. Cyclosporine A in hospitalized COVID-19 pneumonia patients to prevent the development of interstitial lung disease: a pilot randomized clinical trial

    Scientific Reports, Vol. 14, Núm. 1

2019

  1. Secukinumab does not impair the immunogenic response to the influenza vaccine in patients

    RMD Open, Vol. 5, Núm. 2

2017

  1. Development of an activity disease score in patients with uveitis (UVEDAI)

    Rheumatology International, Vol. 37, Núm. 4, pp. 647-656